ARTICLE | Targets & Mechanisms
Triplet brings a new strategy to Huntington’s disease
Unveils preclinical POC data for its first DNA damage repair target
April 27, 2021 11:30 PM UTC
Preclinical data suggest that with a new target and route of administration, Triplet’s antisense oligonucleotide for Huntington’s disease may be effective where others have fallen ...
BCIQ Company Profiles